Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive approach. Proponents often emphasize the potential for meaningful therapeutic gains, especially in conditions where conventional therapies have proven limited. However, crucially important to assess the substantial financial burden associated with CPI stem cell the